Attenuation of zinc-induced neuronal death by the interaction of growth inhibitory factor with Rab3A in rat hippocampal neurons

Neuroscience Letters

Volumn 358, Issue 3, 2004, Pages 149-152

  Liu, Ying ^a,b   Ren, Hongwei ^a   Wu, Caihong ^a   Bai, Shuhua ^a   Zhang, Xiaokun ^b   Ru, Binggen ^a  

^a PEKING UNIVERSITY   (China)

^b BURNHAM INSTITUTE   (United States)

Author keywords

Growth inhibitory factor; Interaction; Neuronal death; Rab3A; Zinc

Indexed keywords

GROWTH INHIBITOR; GUANINE NUCLEOTIDE BINDING PROTEIN; PROTEIN RAB3A; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; ZINC;

ANIMAL CELL; APOPTOSIS; ARTICLE; BRAIN NERVE CELL; CELL SURVIVAL; DRUG EFFECT; DRUG POTENTIATION; HIPPOCAMPUS; NERVE CELL CULTURE; NERVE CELL NECROSIS; NEUROPROTECTION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANIMALS, NEWBORN; ANNEXIN A5; CELL DEATH; CELLS, CULTURED; DNA DAMAGE; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FLUORESCENT DYES; HIPPOCAMPUS; NERVE DEGENERATION; NERVE TISSUE PROTEINS; NEUROPROTECTIVE AGENTS; RAB3A GTP-BINDING PROTEIN; RATS; RATS, WISTAR; RECOMBINANT FUSION PROTEINS; ZINC;

EID: 1642382190     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2003.12.087     Document Type: Article

References (14)

1. 2+ from brain tissue during activity. Nature. 308:1984;734-736.
2. Brewer G.J., Torricelli J.R., Evege E.K., Price P.J. Optimized survival of hippocampal neurons in B27-supplemented neurobasal, a new serum-free medium combination. J. Neurosci. Res. 35:1993;567-576.
3. Cuajungco M.P., Lees G.J. Diverse effects of metal chelating agents on the neuronal cytotoxicity of zinc in the hippocampus. Brain Res. 799:1998;97-107.
4. Erickson J.C., Sewell A.K., Jensen L.T., Winge D.R., Palmiter R.D. Enhanced neurotrophic activity in Alzheimer's disease cortex is not associated with down-regulation of metallothionein-III (GIF). Brain Res. 649:1994;297-304.
5. Frederickson C.J. Neurobiology of zinc and zinc-containing neurons. Int. Rev. Neurobiol. 31:1989;145-238.
6. Kang Q.H., Chen Q.L., Ren H.W., Ru B.G. Growth inhibitory factor (GIF) directly interacts with G protein-Rab3A. Prog. Biochem. Biophys. 28:2001;880-884.
7. Manzerra P., Behrens M.M., Lorella M.T.C., Wang X.Q., Heidinger V., Tomomi I., Yu S.P., Choi D.W. Zinc induces a Src family kinase-mediated up-regulation of NMDA receptor activity and excitotoxicity. Proc. Natl. Acad. Sci. USA. 98:2001;11055-11061.
8. Milan V., Hasler D.W. Metallothioneins: new functional and structural insights. Curr. Opin. Chem. Biol. 4:2000;177-183.
9. Palumaa P., Eriste E., Njunkova O., Pokras L., Jornvall H., Sillard R. Brain-specific metallothionein-3 has higher metal-binding capacity than ubiquitous metallothioneins and binds metals non-cooperatively. Biochemistry. 41:2002;6158-6163.
10. Regland B., Lehmann W., Abedini I., Blennow K., Jonsson M., Karlsson I., Sjogren M., Wallin A., Xilinas M., Gottfries C.G. Treatment of Alzheimer's disease with clioquinol. Demen. Geriatr. Cogn. Disord. 12:2001;408-414.
11. Samudralwar D.L., Diprete C.C., Ni B.F. Elemental imbalances in the olfactory pathway in Alzheimer's disease. J. Neurol. Sci. 130:1995;139-145.
12. Vogt K., Mellor J., Tong G., Nicoll R. The actions of synaptically released zinc at hippocampal mossy fiber synapses. Neuron. 26:2000;187-196.
13. Wu D.Q., Shen J., Ru B.G. Expression and purification of human Metallothionein-3/growth inhibitory factor in Escherichia coli. Protein Pept. Lett. 5:1998;95-100.
14. Yu W.H., Lukiw W.J., Bergeron C., Niznik H.B., Fraser P.E. Metallothionein III is reduced in Alzheimer's disease. Brain Res. 894:2001;37-45.